Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Springer

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Organic & Biomolecular Chemistry|December 2, 2015
A novel protocol for the one-pot borylation/Suzuki reaction provides easy access to hinge-binding groups for kinase inhibitorsA Hooper, A Zambon, C J Springer
The British Journal of Nutrition|September 1, 1987
Raw soya-bean flour increases cholecystokinin release in manJ Calam, J C Bojarski, C J Springer
Journal of Medicinal Chemistry|July 22, 1994
Novel prodrugs of alkylating agents derived from 2-fluoro- and 3-fluorobenzoic acids for antibody-directed enzyme prodrug therapyC J Springer, I Niculescu-Duvaz, R B Pedley
The International Journal of Clinical and Experimental Hypnosis|July 1, 1977
Group methods of increasing hypnotic susceptibilityC J Springer, L B Sachs, J E Morrow
Bioconjugate Chemistry|February 14, 1998
Gene-directed enzyme prodrug therapyI Niculescu-Duvaz, R Spooner, R Marais, et al.
Anti-Cancer Drug Design|November 1, 1991
Comparison of half-lives and cytotoxicity of N-chloroethyl-4-amino and N-mesyloxyethyl-benzoyl compounds, products of prodrugs in antibody-directed enzyme prodrug therapy (ADEPT)C J Springer, P Antoniw, K D Bagshawe, et al.
Journal of Medicinal Chemistry|April 11, 1997
Mustard prodrugs for activation by Escherichia coli nitroreductase in gene-directed enzyme prodrug therapyF Friedlos, W A Denny, B D Palmer, et al.
Cancer Gene Therapy|November 4, 2000
In suicide gene therapy, the site of subcellular localization of the activating enzyme is more important than the rate at which it activates prodrugR A Spooner, J Martin, F Friedlos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994
Antibody directed enzyme prodrug therapy (ADEPT). A review of some theoretical, experimental and clinical aspectsK D Bagshawe, S K Sharma, C J Springer, et al.
Neuroscience Letters|October 24, 1985
On the immunology of nerve growth factorB E Banks, F L Pearce, C J Springer, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Organic & Biomolecular Chemistry|December 2, 2015
A novel protocol for the one-pot borylation/Suzuki reaction provides easy access to hinge-binding groups for kinase inhibitorsA Hooper, A Zambon, C J Springer
The British Journal of Nutrition|September 1, 1987
Raw soya-bean flour increases cholecystokinin release in manJ Calam, J C Bojarski, C J Springer
Journal of Medicinal Chemistry|July 22, 1994
Novel prodrugs of alkylating agents derived from 2-fluoro- and 3-fluorobenzoic acids for antibody-directed enzyme prodrug therapyC J Springer, I Niculescu-Duvaz, R B Pedley
The International Journal of Clinical and Experimental Hypnosis|July 1, 1977
Group methods of increasing hypnotic susceptibilityC J Springer, L B Sachs, J E Morrow
Bioconjugate Chemistry|February 14, 1998
Gene-directed enzyme prodrug therapyI Niculescu-Duvaz, R Spooner, R Marais, et al.
Anti-Cancer Drug Design|November 1, 1991
Comparison of half-lives and cytotoxicity of N-chloroethyl-4-amino and N-mesyloxyethyl-benzoyl compounds, products of prodrugs in antibody-directed enzyme prodrug therapy (ADEPT)C J Springer, P Antoniw, K D Bagshawe, et al.
Journal of Medicinal Chemistry|April 11, 1997
Mustard prodrugs for activation by Escherichia coli nitroreductase in gene-directed enzyme prodrug therapyF Friedlos, W A Denny, B D Palmer, et al.
Cancer Gene Therapy|November 4, 2000
In suicide gene therapy, the site of subcellular localization of the activating enzyme is more important than the rate at which it activates prodrugR A Spooner, J Martin, F Friedlos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994
Antibody directed enzyme prodrug therapy (ADEPT). A review of some theoretical, experimental and clinical aspectsK D Bagshawe, S K Sharma, C J Springer, et al.
Neuroscience Letters|October 24, 1985
On the immunology of nerve growth factorB E Banks, F L Pearce, C J Springer, et al.
Pageof 7